RAC 2.20% $1.78 race oncology ltd

The RAC 3-Pillar Trifecta, page-183

  1. 11,249 Posts.
    lightbulb Created with Sketch. 29637
    Lol. I just increased it. That's without speculative potential for applications outside of Oncology. Just remember though, any potential partnership or buyout will be on the basis of clinical trials readouts / results and preclinical data. Applications beyond oncology are a nice carrot.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.